Recursion Pharmaceuticals (RXRX) Earnings Date & Reports
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
RXRX is expected to report earnings to fall 1.09% to -21 cents per share on November 11
Q3'26
Est.
$-0.22
Q1'26
Beat
by $0.04
Q4'25
Beat
by $0.09
Q3'25
Beat
by $0.01
Q2'25
Missed
by $0.06
The last earnings report on May 06 showed earnings per share of -21 cents, beating the estimate of -25 cents. With 6.68M shares outstanding, the current market capitalization sits at 1.78B.